A Phase 3 Extension Study of Duvelisib and Ofatumumab in Patients With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma Previously Enrolled in Study IPI-145-07
Phase of Trial: Phase III
Latest Information Update: 04 Jul 2018
At a glance
- Drugs Duvelisib (Primary) ; Ofatumumab
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Sponsors Infinity Pharmaceuticals; Verastem Oncology
- 29 Jun 2018 This trial has been completed in Germany.
- 16 Jun 2018 Results presented in the Verastem Oncology media release.
- 16 Jun 2018 According to a Verastem Oncology media release, data from this trial was presented at the 23rd Congress of the European Hematology Association (EHA) (June 2018).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History